Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS

v3.24.1.1.u2
FINANCIAL INSTRUMENTS
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
FINANCIAL INSTRUMENTS

NOTE 4 FINANCIAL INSTRUMENTS

The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued liabilities, derivative instruments and debt.

Derivative Instruments

The following table reflects the contracted volumes and weighted average prices under the terms of the Company’s open derivative contracts as of March 31, 2024:

Average

Instrument

Daily

Total

Weighted

Weighted

Weighted

Period

    

Type

    

Volumes (1)

    

Volumes (1)

    

Strike Price

    

Put Price

    

Call Price

Natural Gas - Henry Hub (NYMEX)

(Mmbtu)

(Mmbtu)

($/Mmbtu)

($/Mmbtu)

($/Mmbtu)

Apr 2024 - Dec 2024

calls

65,000

17,875,000

$

$

$

6.13

Jan 2025 - Mar 2025

calls

62,000

5,580,000

$

$

$

5.50

Apr 2024 - Dec 2024 (1)

swaps

65,455

18,000,000

$

2.39

$

$

Jan 2025 - Mar 2025 (1)

swaps

63,333

5,700,000

$

2.72

$

$

Apr 2025 - Dec 2025 (1)

puts

62,182

17,100,000

$

$

2.27

$

Jan 2026 - Dec 2026 (1)

puts

55,890

20,400,000

$

$

2.35

$

Jan 2027 - Dec 2027 (1)

puts

52,306

19,200,000

$

$

2.37

$

Jan 2028 - Apr 2028 (1)

puts

49,587

6,000,000

$

$

2.50

$

(1)

MMbtu – Million British Thermal Units

The Company has elected not to designate its derivative instruments contracts for hedge accounting. Accordingly, commodity derivatives are recorded on the Condensed Consolidated Balance Sheets at fair value with settlements of such contracts, and changes in the unrealized fair value, recorded as Derivative gain, net on the Condensed Consolidated Statements of Operations in each period presented.

The fair value of the Company’s derivative financial instruments was recorded in the Condensed Consolidated Balance Sheets as follows (in thousands):

    

March 31, 

    

December 31, 

2024

2023

Prepaid expenses and other current assets

$

2,801

$

1,180

Other assets

 

6,747

 

10,068

Accrued liabilities

 

5,046

 

6,267

Other liabilities

2,756

The Company measures the fair value of its derivative instruments by applying the income approach, using models with inputs that are classified within Level 2 of the valuation hierarchy. The income approach converts expected future cash flows to a present value amount based on market expectations. The inputs used for the fair value measurement of derivative financial instruments are the exercise price, the expiration date, the settlement date, notional quantities, the implied volatility, the discount curve with spreads and published commodity future prices.

Although the Company has master netting arrangements with its counterparties, the amounts recorded on the Condensed Consolidated Balance Sheets are on a gross basis.

The impact of commodity derivative contracts on the Condensed Consolidated Statements of Operations were as follows (in thousands):

Three Months Ended March 31, 

    

2024

    

2023

    

Realized (gain) loss

$

(3,755)

$

230

Unrealized gain

(1,122)

(39,470)

Derivative gain, net

$

(4,877)

$

(39,240)

Debt

The following table presents the net values and estimated fair values of the Company’s debt (in thousands):

    

March 31, 2024

    

December 31, 2023

Net Value

    

Fair Value

    

Net Value

    

Fair Value

Term Loan

$

111,425

$

108,294

$

111,107

$

108,467

11.75% Notes

270,417

 

284,818

 

269,910

 

283,443

TVPX Loan

9,386

9,967

9,587

10,156

Total

$

391,228

$

403,079

$

390,604

$

402,066

The fair value of the TVPX Loan and the Term Loan were measured using a discounted cash flows model and current market rates. The fair value of the 11.75% Notes was measured using quoted prices, although the market is not a highly liquid market. The fair value of debt was classified as Level 2 within the valuation hierarchy.